STANDARD BIOTOOLS INC. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

STANDARD BIOTOOLS INC. reported Revenue From Contract With Customer Excluding Assessed Tax of $85.33 million for the year ending 2025.

  • STANDARD BIOTOOLS INC. showed a decrease of -6.2% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
  • This data is from STANDARD BIOTOOLS INC.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
  • XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 10 years of available data (2016 to 2025), STANDARD BIOTOOLS INC.'s Revenue From Contract With Customer Excluding Assessed Tax has declined by 18.3%.
  • Historical annual values: Fiscal year 2025: $85.33 million | Fiscal year 2024: $91.01 million | Fiscal year 2023: $106.34 million | Fiscal year 2022: $97.95 million | Fiscal year 2021: $130.58 million | Fiscal year 2020: $138.14 million | Fiscal year 2019: $117.24 million | Fiscal year 2018: $112.96 million | Fiscal year 2017: $101.94 million | Fiscal year 2016: $104.45 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: